Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Li, Xueli
NCT05935176: Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)	Active, not recruiting	4	660	RoW	MCV4	CanSino Biologics Inc.	Epidemic Meningitis	10/24	01/25
PROEM, NCT06225947: Patient-Reported Outcomes for Lemborexant in Chinese Participants With Insomnia	Recruiting	N/A	200	RoW	Lemborexant 5 MG, DAYVIGO	Guangdong Provincial People's Hospital, Nanfang Hospital, Southern Medical University	Insomnia	03/25	06/25